Your browser doesn't support javascript.
loading
All-Atom Simulations Reveal a Key Interaction Network in the HLA-E/NKG2A/CD94 Immune Complex Fine-Tuned by the Nonameric Peptide.
Prasnikar, Eva; Perdih, Andrej; Borisek, Jure.
Afiliação
  • Prasnikar E; National Institute of Chemistry, Hajdrihova 19, 1000 Ljubljana, Slovenia.
  • Perdih A; Graduate School of Biomedicine, Faculty of Medicine, University of Ljubljana, Vrazov trg 2, 1000 Ljubljana, Slovenia.
  • Borisek J; National Institute of Chemistry, Hajdrihova 19, 1000 Ljubljana, Slovenia.
J Chem Inf Model ; 61(7): 3593-3603, 2021 07 26.
Article em En | MEDLINE | ID: mdl-34196180
ABSTRACT
Natural killer (NK) cells, an important part of the innate immune system, can clear a wide variety of pathological challenges, including tumor, senescent, and virally infected cells. They express various activating and inhibitory receptors on their surface, and the balance of interactions between them and specific ligands displayed on the surface of target cells is critical for NK cell cytolytic function and target cell protection. The CD94/NKG2A heterodimer is one of the inhibitory receptors that interacts with its trimeric ligand consisting of HLA-E, ß2m, and a nonameric peptide. Here, multi-microsecond-long all-atom molecular dynamics simulations of eight immune complexes elucidate the subtleties of receptor (NKG2A/CD94)-ligand (HLA-E/ß2m/peptide) molecular recognition that mediate the NK cell protection from a geometric and energetic perspective. We identify key differences in the interactions between the receptor and ligand complexes, which are via an entangled network of hydrogen bonds fine-tuned by the ligand-specific nonameric peptide. We further reveal that the receptor protein NKG2A regulates the NK cell activity, while its CD94 partner forms the majority of the energetically important interactions with the ligand. This knowledge rationalizes the atomistic details of the fundamental NK cell protection mechanism and may enable a variety of opportunities in rational-based drug discovery for diverse pathologies including viral infections and cancer and elimination of senescent cells associated with potential treatment of many age-related diseases.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antígenos de Histocompatibilidade Classe I / Subfamília D de Receptores Semelhantes a Lectina de Células NK / Subfamília C de Receptores Semelhantes a Lectina de Células NK / Complexo Antígeno-Anticorpo Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antígenos de Histocompatibilidade Classe I / Subfamília D de Receptores Semelhantes a Lectina de Células NK / Subfamília C de Receptores Semelhantes a Lectina de Células NK / Complexo Antígeno-Anticorpo Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article